Melina Beloso
Research Subjects
Melina Beloso has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- María José Sadonio
Servicio de Clínica Médica, Hospital J. B. Iturraspe, Santa Fe, Argentina
2 shared publications - Maximiliano Gabriel Castro
Servicio de Clínica Médica, Hospital J. B. Iturraspe, Santa Fe, Argentina. Facultad de Ciencias Médicas, Universidad Nacional del Litoral, Santa Fe, Argentina
2 shared publications - Agust´ín Martínez
Servicio de Clínica Médica, Hospital J. B. Iturraspe
1 shared publication - Ana Paula Amato
Servicio de Clínica Médica, Hospital J.B. Iturraspe, Santa Fe, Argentina
1 shared publication - Ana Verónica Willa
Hospital Regional José Bernardo Iturraspe. Servicio de Clínica Médica
1 shared publication - Federico Rafael Galluccio
Servicio de Clínica Médica, Hospital J.B. Iturraspe, Santa Fe, Argentina; Facultad de Medicina, Universidad Nacional del Litoral, Santa Fe, Argentina
1 shared publication
Latest Publications
- Open Access
- 26 June 2025
- Published by Universidad Nacional de Córdoba in Revista de la Facultad de Ciencias Médicas de Córdoba
- Vol. 82 (2) , 237-252
Variabilidad en el tamizaje de la infección por el Virus de la Inmunodeficiencia Humana
Introduction: Due to potential disruptions in HIV care services caused by COVID-19, this study aimed to evaluate the variability in HIV screening between 2019 and 2022 among adults hospitalized in the general ward of a tertiary care hospital in Santa Fe. Materials and Methods: This ambispective and observational study evaluated the request for HIV serologic screening in patients selected through randomized sampling at a 2:1 ratio from October to December of the years 2019 to 2022. The impact of the COVID-19 pandemic during 2020 was compared to 2019, followed by the impact of an institutional intervention aimed at increasing the rate of HIV screening requests. Results: A total of 995 subjects were included. HIV screening was requested for 47.4% (n=472) of them, with a positivity rate of 1.7% (n=8). In 2020, HIV screening decreased compared to 2019 (34% vs. 43.9%, p<0.001), and increased to 84.2% in 2022 (p<0.001). In the multivariate analysis, the odds of HIV screening decreased with age (OR 0.986), while hospital admission in 2019 and 2022 (OR 1.48 y 9.76, respectively) increased it. Discussion: The COVID-19 pandemic exacerbated the already low rate of HIV screening requests, which was also influenced by the age of the subjects. However, through institutional guidelines, this situation was successfully reversed in 2022.
- 26 June 2025
- Published by Universidad Nacional de Córdoba in Revista de la Facultad de Ciencias Médicas de Córdoba
- Vol. 82 (2) , 237-252
Open AccessVariabilidad en el tamizaje de la infección por el Virus de la Inmunodeficiencia Humana
Introduction: Due to potential disruptions in HIV care services caused by COVID-19, this study aimed to evaluate the variability in HIV screening between 2019 and 2022 among adults hospitalized in the general ward of a tertiary care hospital in Santa Fe. Materials and Methods: This ambispective and observational study evaluated the request for HIV serologic screening in patients selected through randomized sampling at a 2:1 ratio from October to December of the years 2019 to 2022. The impact of the COVID-19 pandemic during 2020 was compared to 2019, followed by the impact of an institutional intervention aimed at increasing the rate of HIV screening requests. Results: A total of 995 subjects were included. HIV screening was requested for 47.4% (n=472) of them, with a positivity rate of 1.7% (n=8). In 2020, HIV screening decreased compared to 2019 (34% vs. 43.9%, p<0.001), and increased to 84.2% in 2022 (p<0.001). In the multivariate analysis, the odds of HIV screening decreased with age (OR 0.986), while hospital admission in 2019 and 2022 (OR 1.48 y 9.76, respectively) increased it. Discussion: The COVID-19 pandemic exacerbated the already low rate of HIV screening requests, which was also influenced by the age of the subjects. However, through institutional guidelines, this situation was successfully reversed in 2022.
- Open Access
- 12 November 2023
- Published by Universidad Nacional del Litoral in SigMe
- No. 1,p. e0006
Criptococosis meníngea en personas que viven con VIH
La criptococosis meníngea es una infección oportunista que afecta a personas que viven con el virus de la inmunodeficiencia humana (PVVIH) con alto nivel de inmunosupresión. La misma se asocia a una elevada morbimortalidad. Debido a la limitada disponibilidad de estudios regionales publicados, se propone describir las principales características clínico-bioquímicas, conducta terapéutica y evolución de una serie de PVVIH con criptococosis meníngea en un hospital de referencia para la región centro-norte de la provincia de Santa Fe (Argentina). Se incluyeron 10 pacientes, con una edad de 44 (61-34) años y una mediana de 3 (30-0) años de evolución de la infección por VIH. Al realizar la primera consulta presentaban una mediana de 15 (40-2) días de evolución, siendo la fiebre el síntoma más común. Todos recibieron tratamiento con anfotericina B liposomal por 26,5 (44-2) días. El cultivo de líquido cefalorraquídeo (LCR) de control a los 14 días de iniciada la terapéutica fue positivo en 5 individuos. Cinco sujetos evolucionaron favorablemente con alta hospitalaria y seguimiento ambulatorio, mientras que cinco requirieron atención en Unidad de Cuidados Intensivos para asistencia respiratoria mecánica. Por otra parte, Cinco de las PVVIH incluidas fallecieron. Meningeal cryptococcosis is an opportunistic infection that affects people with human immunodeficiency virus (PLHIV) with a high level of immunosuppression. It is associated with high morbidity and mortality. Due to the lack of official epidemiological data in Argentina and a limited number of published regional studies, the present paper aims to describe the main clinical-biochemical characteristics, therapeutic management and evolution of a group of PLHIV with meningeal cryptococcosis in a referral hospital of the north-central region of the province of Santa Fe (Argentina). 10 patients were included, aged 44 (61-34) years and a mean of 3 (30-0) years of evolution of the HIV infection. When making the first consultation, they presented 15 (40-2) days of evolution, being fever the most common symptom. All of them received treatment with liposomal amphotericin B for 26.5 (44-2) days. Cerebrospinal fluid (CSF) culture control 14 days after starting therapy was positive in 5 individuals. Five subjects evolved favorably with hospital discharge and outpatient follow-up, while five required attention in the Intensive Care Unit for mechanical respiratory assistance. Five of the PLHIV included died.
- 12 November 2023
- Published by Universidad Nacional del Litoral in SigMe
- No. 1,p. e0006
Open AccessCriptococosis meníngea en personas que viven con VIH
La criptococosis meníngea es una infección oportunista que afecta a personas que viven con el virus de la inmunodeficiencia humana (PVVIH) con alto nivel de inmunosupresión. La misma se asocia a una elevada morbimortalidad. Debido a la limitada disponibilidad de estudios regionales publicados, se propone describir las principales características clínico-bioquímicas, conducta terapéutica y evolución de una serie de PVVIH con criptococosis meníngea en un hospital de referencia para la región centro-norte de la provincia de Santa Fe (Argentina). Se incluyeron 10 pacientes, con una edad de 44 (61-34) años y una mediana de 3 (30-0) años de evolución de la infección por VIH. Al realizar la primera consulta presentaban una mediana de 15 (40-2) días de evolución, siendo la fiebre el síntoma más común. Todos recibieron tratamiento con anfotericina B liposomal por 26,5 (44-2) días. El cultivo de líquido cefalorraquídeo (LCR) de control a los 14 días de iniciada la terapéutica fue positivo en 5 individuos. Cinco sujetos evolucionaron favorablemente con alta hospitalaria y seguimiento ambulatorio, mientras que cinco requirieron atención en Unidad de Cuidados Intensivos para asistencia respiratoria mecánica. Por otra parte, Cinco de las PVVIH incluidas fallecieron. Meningeal cryptococcosis is an opportunistic infection that affects people with human immunodeficiency virus (PLHIV) with a high level of immunosuppression. It is associated with high morbidity and mortality. Due to the lack of official epidemiological data in Argentina and a limited number of published regional studies, the present paper aims to describe the main clinical-biochemical characteristics, therapeutic management and evolution of a group of PLHIV with meningeal cryptococcosis in a referral hospital of the north-central region of the province of Santa Fe (Argentina). 10 patients were included, aged 44 (61-34) years and a mean of 3 (30-0) years of evolution of the HIV infection. When making the first consultation, they presented 15 (40-2) days of evolution, being fever the most common symptom. All of them received treatment with liposomal amphotericin B for 26.5 (44-2) days. Cerebrospinal fluid (CSF) culture control 14 days after starting therapy was positive in 5 individuals. Five subjects evolved favorably with hospital discharge and outpatient follow-up, while five required attention in the Intensive Care Unit for mechanical respiratory assistance. Five of the PLHIV included died.